K073277 is an FDA 510(k) clearance for the ROCHE-CREACTIVE PROTEIN (LATEX). This device is classified as a System, Test, C-reactive Protein (Class II - Special Controls, product code DCN).
Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on March 6, 2008, 106 days after receiving the submission on November 21, 2007.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5270.
| 510(k) Number | K073277 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | November 21, 2007 |
| Decision Date | March 06, 2008 |
| Days to Decision | 106 days |
| Submission Type | Special |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | DCN — System, Test, C-reactive Protein |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.5270 |